Molecular Docking and Pharmacoinformatics Study of Bioactive Compounds in Sweet Flag (Acorus calamus L.) as Antidiabetic Agents Targeting α-Glucosidase
DOI:
10.29303/jpm.v20i4.8994Published:
2025-06-26Issue:
Vol. 20 No. 4 (2025): Special IssueKeywords:
Acorus calamus L.; α-glukosidase; Antidiabetic; In Silico; Molecular DockingArticles
Downloads
How to Cite
Downloads
Metrics
Abstract
Diabetes mellitus (DM) is a chronic metabolic disorder whose prevalence continues to rise, necessitating safer and more effective therapeutic alternatives. This study aims to explore the potential of active compounds from the calamus plant (Acorus calamus L.) as candidates for α-glucosidase enzyme inhibitors using an in silico approach. Pharmacokinetic screening, toxicity prediction, and Lipinski's Rule of Five screening were conducted to assess the pharmacological suitability of the compounds, followed by molecular docking using MOE 2022 software. The results of the study showed that several compounds from the jeringau plant (Acorus calamus L.), such as galgravin and veraguensin, have strong binding affinity to the α-glucosidase enzyme with docking scores of −8.40 kcal/mol and −8.37 kcal/mol, respectively. Pharmacokinetic prediction results indicate that the test compounds have good absorption and meet druglikeness criteria. This study suggests that active compounds from jeringau have potential for development as natural-based antidiabetic agents. However, this research is limited to computational analysis without experimental data support, and compound selection is based on GC-MS results without further isolation or characterization. Further studies through in vitro and in vivo testing, as well as molecular dynamics simulations and ADMET predictions, are required to validate these findings comprehensively.
References
E. Q. Syahputri et al., “Kajian pemanfaatan tanaman obat sebagai antidiabetes alami,” vol. 5, no. 2, pp. 1485–1499, 2024.
IDF, “Type 2 diabetes in adults: management,” Natl. Inst. Heal. Care Excell., pp. 1–59, 2022, [Online]. Available: www.nice.org.uk/guidance/ng28
R. Arif et al., “Molecular Docking and Simulation Studies of Antidiabetic Agents Devised from Hypoglycemic Polypeptide-P of Momordica charantia,” Biomed Res. Int., vol. 2021, 2021, doi: 10.1155/2021/5561129.
A. Mohammed and N. Tajuddeen, “Antidiabetic compounds from medicinal plants traditionally used for the treatment of diabetes in Africa: A review update (2015–2020),” South African J. Bot., vol. 146, pp. 585–602, 2022, doi: 10.1016/j.sajb.2021.11.018.
K. G. P. Wasana, A. P. Attanayake, K. A. P. W. Jayatilaka, and T. P. Weerarathna, “Antidiabetic Activity of Widely Used Medicinal Plants in the Sri Lankan Traditional Healthcare System: New Insight to Medicinal Flora in Sri Lanka,” Evidence-based Complement. Altern. Med., vol. 2021, 2021, doi: 10.1155/2021/6644004.
J. J. Gout-Zwart, L. A. de Jong, L. Saptenno, and M. J. Postma, “Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands,” PharmacoEconomics - Open, vol. 4, no. 2, pp. 321–330, 2020, doi: 10.1007/s41669-019-00179-6.
D. Jini, S. Sharmila, A. Anitha, M. Pandian, and R. M. H. Rajapaksha, “In vitro and in silico studies of silver nanoparticles (AgNPs) from Allium sativum against diabetes,” Sci. Rep., vol. 12, no. 1, pp. 1–13, 2022, doi: 10.1038/s41598-022-24818-x.
P. Ansari, M. P. Hannon-Fletcher, P. R. Flatt, and Y. H. A. Abdel-Wahab, “Effects of 22 traditional anti-diabetic medicinal plants on DPP-IV enzyme activity and glucose homeostasis in high-fat fed obese diabetic rats,” Biosci. Rep., vol. 41, no. 1, pp. 1–15, 2021, doi: 10.1042/BSR20203824.
F. A. Hawa and R. Ruswanto, “Molecular Docking Senyawa Sinamaldehida Kayu Manis Sebagai Penghambat Enzim DPP IV Untuk Terapi Diabetes Mellitus Tipe 2 Molecular Docking Cinnamaldehyde from Cinnamon as DPP IV Inhibitor for Treatment of Type 2 Diabetes Mellitus,” Pros. Semin. Nas. dan Penelit. Kesehat., pp. 178–188, 2021.
T. I. Adelusi et al., “GCMS fingerprints and phenolic extracts of Allium sativum inhibit key enzymes associated with type 2 diabetes,” J. Taibah Univ. Med. Sci., vol. 18, no. 2, pp. 337–347, 2023, doi: 10.1016/j.jtumed.2022.09.011.
I. M. W. A. Putra, N. Fakhrudin, A. Nurrochmad, and S. Wahyuono, “Antidiabetic activity of Coccinia grandis (L.) Voigt: Bioactive constituents, mechanisms of action, and synergistic effects,” J. Appl. Pharm. Sci., vol. 12, no. 1, pp. 041–054, 2022, doi: 10.7324/JAPS.2021.120103.
M. Przeor, “Some Common Medicinal Plants with Antidiabetic Activity, Known and Available in Europe (A Mini-Review),” Pharmaceuticals, vol. 15, no. 1, 2022, doi: 10.3390/ph15010065.
F. Frengki et al., “SKRINING POTENSI SENYAWA AKTIF RIMPANG JERINGAU (Acorus calamus, L) SEBAGAI INHIBITOR TERHADAP RESEPTOR α-GLUCOSIDASE MANUSIA SECARA IN SILICO,” J. Ilm. Mhs. Vet. Fak. Kedokt. Hewan Univ. Syiah Kuala, vol. 6, no. 4, p. 243, 2022, [Online]. Available: www.rscb.org
N. Krishnan, P. K. Singh, M. Sakthivelu, P. Velusamy, S. C. B. Gopinath, and P. Raman, “Influence of thermal treatment on extraction and characteristics of phytochemicals from rhizome of Acorus calamus L,” Biomass Convers. Biorefinery, no. May, 2022, doi: 10.1007/s13399-022-03415-y.
S. Amalia, L. S. Hasibuan, N. A. Arianti, A. G. Fasya, D. C. Dewi, and D. K. Kadarani, “Sweet flag (Acorus calamus L.) rhizomes chromatography column isolates potential as rich antioxidant compounds,” Indones. J. Fundam. Appl. Chem., vol. 9, no. 2, pp. 66–73, 2024, doi: 10.24845/ijfac.v9.i2.66.
I. M. Sugata, I. K. Darmo Suputra, P. Emy Suryanti, M. G. Juniartha, and I. G. A. A. Kartika, “Profil Fitokimia dan Aktivitas Antibakteri dari Massoia aromatic Becc., Acorus calamus L., dan Allium sativum L. terhadap Bakteri Penyebab Rinosinusitis,” J. Ilm. Medicam., vol. 9, no. 2, pp. 106–114, 2023, doi: 10.36733/medicamento.v9i2.5961.
Z. Hao et al., “Chemical constituents from Acorus calamus with potent anti-diabetic and hepatoprotective activities,” Fitoterapia, vol. 169, no. September, pp. 1–5, 2023, doi: 10.1016/j.fitote.2023.105591.
Z. Y. Hao et al., “Alkaloids from the rhizomes of Acorus calamus and their PPARα, PPARγ, and glucokinase-activating activities,” Phytochem. Lett., vol. 45, no. May, pp. 37–43, 2021, doi: 10.1016/j.phytol.2021.07.009.
R. Kashyap, S. Patel, and C. Dewangan, “Acorus Calamus : An Ancient Remedy with Modern Medicinal Applications,” vol. 2, no. 2, pp. 140–148, 2025.
A. D. Sarie and M. R. Utami, “Bioactivity Analysis of Chalcone-Derived Compounds Based on In-Silico Molecular Docking Study,” J. Pijar MIPA, vol. 20, no. 2, pp. 251–259, 2025.
M. I. Sugiharto, Y. R. Bintari, and D. S. Damayanti, “Mekanisme Senyawa Aktif Daun Sirsak (Annona muricata Linn.) Sebagai Anti Diabetes : Studi In Silico,” J. Kedokt. Komunitas, vol. 9, no. 2, pp. 1–13, 2021.
N. Nurlelasari et al., “Studi In Silico Aktivitas Senyawa Steroid Terhadap Antikanker Payudara Menggunakan Estrogen Alfa (ER-α),” ALCHEMY J. Penelit. Kim., vol. 19, no. 1, p. 44, 2023, doi: 10.20961/alchemy.19.1.62384.44-52.
W. P. Salim, Y. O. Hutahaean, and F. A. Sitohang, “Molecular Docking and Pharmacoinformatics Study of Curcumin and Arturmeron Compounds in Turmeric Plants (Curcuma Longa Linn.) as Antihypertensive,” J. Sains dan Kesehat., vol. 3, no. 1, pp. 242–247, 2024.
R. Mardianingrum, K. R. Bachtiar, S. Susanti, A. N. Aas Nuraisah, and R. Ruswanto, “Studi In Silico Senyawa 1,4-Naphthalenedione-2-Ethyl-3-Hydroxy sebagai Antiinflamasi dan Antikanker Payudara,” ALCHEMY J. Penelit. Kim., vol. 17, no. 1, p. 83, 2021, doi: 10.20961/alchemy.17.1.43979.83-95.
Annisa Fitriyani Suryana, Hilda Aprilia, and Taufik Muhammad Fakih, “Uji Aktivitas In Silico Senyawa Amritoside, Tinosporaside dan Turunannya sebagai Kanditat Senyawa,” Bandung Conf. Ser. Pharm., vol. 2, no. 2, pp. 1–10, 2022, doi: 10.29313/bcsp.v2i2.4369.
H. S. Wu et al., “Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo,” J. Ethnopharmacol., vol. 123, no. 2, pp. 288–292, 2009, doi: 10.1016/j.jep.2009.03.004.
V. Ivanović, M. Rančić, B. Arsić, and A. Pavlović, “Lipinski’s rule of five, famous extensions and famous exceptions,” Chem. Naissensis, vol. 3, no. 1, pp. 171–181, 2020, doi: 10.46793/chemn3.1.171i.
C. A. Lipinski, “Lead- and drug-like compounds: The rule-of-five revolution,” Drug Discov. Today Technol., vol. 1, no. 4, pp. 337–341, 2004, doi: 10.1016/j.ddtec.2004.11.007.
N. Yulia and L. Setiyabudi, “Skrining Fitokimia dan Uji Aktivitas Antibakteri Ekstrak Jeringau dan Brotowali terhadap Streptococcus pyogenes,” Pros. Semin. Nas. dan Disem. Penelit. Dosen, vol. 1, no. 1, pp. 36–41, 2021.
N. Frimayanti, A. Lukman, and L. Nathania, “Studi molecular docking senyawa 1,5-benzothiazepine sebagai inhibitor dengue DEN-2 NS2B/NS3 serine protease,” Chempublish J., vol. 6, no. 1, pp. 54–62, 2021, doi: 10.22437/chp.v6i1.12980.
P.- Purwaniati, “Molecular Docking Study on COVID-19 Drug Activity of N-(2-phenylethyl)methanesulfonamide Derivatives as Main Protease Inhibitor,” ad-Dawaa’ J. Pharm. Sci., vol. 3, no. 1, pp. 1–11, 2020, doi: 10.24252/djps.v3i1.13945.
D. Ramírez and J. Caballero, “Is It Reliable to Take the Molecular Docking Top Scoring Position as the Best Solution without Considering Available Structural Data?,” Molecules, vol. 23, no. 5, pp. 1–17, 2018, doi: 10.3390/molecules23051038.
R. Arcinthya Rachmania, Supandi;, and O. Anggun Larasati, “Senyawa diterpenoid lakton herba sambiloto (,” Pharmacy, vol. 12, no. 02, pp. 210–222, 2015.
Author Biographies
Rani Sakila Nasution, Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang
Indang Dewata, 1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang
Nofri Yuhelman, 1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang
Neny Sandrawati, Department of Cosmetic Technology, Vocational School, Universitas Negeri Padang
Arif Juliari Kusnanda, 1Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Negeri Padang
License
Copyright (c) 2025 Rani Sakila Nasution, Indang Dewata, Nofri Yuhelman, Neny Sandrawati, Arif Juliari Kusnanda
This work is licensed under a Creative Commons Attribution 4.0 International License.
The following terms apply to authors who publish in this journal:
1. Authors retain copyright and grant the journal first publication rights, with the work simultaneously licensed under a Creative Commons Attribution License 4.0 International License (CC-BY License) that allows others to share the work with an acknowledgment of the work's authorship and first publication in this journal.
2. Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., posting it to an institutional repository or publishing it in a book), acknowledging its initial publication in this journal.
3. Before and during the submission process, authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website), as this can lead to productive exchanges as well as earlier and greater citation of published work (See The Effect of Open Access).
